Mergers & Acquisitions Mergers & Acquisitions

AbbVie wins EU clearance for $63 billion buyout of Allergan

By Natalie McNelis
  • 10 Jan 2020 08:30
  • 10 Jan 2020 08:40

Global biopharmaceutical company AbbVie has received EU approval for its $63 billion bid to acquire its rival Allergan.

Approval is conditioned on the divestment of a pipeline Allergan product for the treatment of inflammatory bowel diseases.

In announcing the approval today (see here), EU competition chief Margrethe Vestager drew

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News